IL2 and neoplasm: Interestingly, even treated with a high dose (120 μg) of IL-2–blocking Abs, KO mice lacking tumor-infiltrating Tregs displayed a relatively high frequency (~79%) of CD44hiCD62lo CD8+ TILs, comparable to that in WT mice without IL-2 blockade (Supplemental Figure 14B).